Skip to search formSkip to main contentSkip to account menu

interferon beta-1b 0.3 MG Injection [Extavia]

Known as: EXTAVIA KIT, INTERFERON BETA-1B 0.25 mg in 1.0 mL SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Extavia], Extavia 0.3 MG Injection 
National Institutes of Health

Related topics

Related topics

10 relations
Albumin Human, USPDrug AllergyExtaviaInjection

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis
© 2018 The Authors. Published by SEEd srl. This is an open access article under the CC BY-NC 4.0 license (https://creativecommons… 
2015
2015
Interferones beta (Avonex®, Betaferon®, Extavia®, Rebif®: riesgo de microangiopatía trombótica y síndrome nefrótico
2013
2013
Ocular side effects of drugs used in the treatment of multiple sclerosis
2012
2012
Farmacoutilizzazione e considerazioni economiche nella terapia della sclerosi multipla: il ruolo della Received Daily Dose
BackgroundMultiple sclerosis, a demyelinating disease of the central nervous system, is the most common cause of neurological… 
2009
2009
FDA actions in brief, October 2009 (Sabril, Helixate FS, Valcyte, Metozolv ODT, Xyzal, Zevalin, Extavia, Astepro, Zenpep, Bepreve)
Recent FDA approvals (through October 2009) related to Sabril, Helixate FS, Valcyte, Metozolv ODT, Xyzal, Zevalin, Extavia… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)